|
16-May-2012
Elsevier Global Medical News
Neoadjuvant abiraterone helped clear tumors in one-third of men with localized, high-risk prostate...
|
16-May-2012
Elsevier Global Medical News
After initially turning it down – and being pressured to reevaluate by the U.K. Department of...
|
30-Apr-2012
Elsevier Global Medical News
Pazopanib, an angiogenesis inhibitor marketed as Votrient, has been approved for the treatment of...
|
27-Apr-2012
Elsevier Global Medical News
Everolimus has become the first drug approved for the treatment of noncancerous renal...
|
23-Apr-2012
Elsevier Global Medical News
CHICAGO (EGMN) – Maintenance immunotherapy with low-dose interleukin-2 and 13-cis-retinoic acid...
|
16-Apr-2012
Elsevier Global Medical News
A comparison of three radiotherapies for nonmetastatic prostate cancer supports the widespread use...
|
16-Apr-2012
Elsevier Global Medical News
CHICAGO (EGMN) – About half of men with castration-resistant prostate cancer demonstrated...
|
04-Apr-2012
Elsevier Global Medical News
People who receive a cancer diagnosis are at markedly increased risk for suicide and for fatal...
|
20-Mar-2012
Elsevier Global Medical News
SILVER SPRING, MARYLAND (EGMN) – A U.S. Food and Drug Administration advisory panel supports...
|
19-Mar-2012
“The Pink Sheet”
Merck and development partner Ariad Pharmaceuticals face a seemingly formidable task at the March...
|
|
